Home Newsfeeds Event Software Company Cvent Explores Sale, WSJ Reports

Event Software Company Cvent Explores Sale, WSJ Reports

https://www.wsj.com/articles/event-software-company-cvent-explores-sale-11675198077?mod=tech_lead_pos11

byBenzinga Newsdesk

February 1, 2023

1 minute read

https://www.wsj.com/articles/event-software-company-cvent-explores-sale-11675198077?mod=tech_lead_pos11

$100 Invested In This Stock 10 Years Ago Would Be Worth $3,800 Today

By Benzinga Insights

October 3, 11:12 AM

NVIDIA (NASDAQ:NVDA) has outperformed the market over the past 10 years by 34.45% on an annualized basis producing an average annual return of 44.17%. Currently, NVIDIA has a market capitalization of $311.34 billion.

NVDA

BMO Capital Maintains Outperform on Capital One Financial, Lowers Price Target to $141

By Benzinga Newsdesk

January 25, 8:29 AM

BMO Capital analyst James Fotheringham maintains Capital One Financial (NYSE:COF) with a Outperform and lowers the price target from $152 to $141.

COF

Seelos Therapeutics’ $5.55M Public Offering As Stock Drop 35%

By Lara Goldstein

November 29, 4:37 PM

Psychedelics biotech Seelos Therapeutics (NASDAQ: SEEL) announced the pricing of a new underwritten public offering for an estimated $5.5 million in gross proceeds. The offering is expected to close on or about Dec. 1, 2023.

SEEL

Sight Sciences’ Cataract Surgery Tech Shows Consistent Lowering Of Eye Pressure, Medication Use

By Vandana Singh

May 23, 1:57 PM

Sight Sciences Inc (NASDAQ: SGHT) published two-year results of the so-called "Romeo" study of the OMNI Surgical System.

SGHT

Event Software Company Cvent Explores Sale, WSJ Reports

Related Posts

$100 Invested In This Stock 10 Years Ago Would Be Worth $3,800 Today

BMO Capital Maintains Outperform on Capital One Financial, Lowers Price Target to $141

Seelos Therapeutics’ $5.55M Public Offering As Stock Drop 35%

Sight Sciences’ Cataract Surgery Tech Shows Consistent Lowering Of Eye Pressure, Medication Use